Evidence map›Paper›PMID 36132312›Full record

ArticleNanoscale advances2020

Enhanced avidin binding to lipid bilayers using PDP-PE lipids with PEG-biotin linkers.

Holly L Birchenough, Marcus J Swann, Egor Zindy, Anthony J Day, Thomas A Jowitt

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Holly L BirchenoughWellcome Trust Centre for Cell-Matrix Research UK t.jowitt@manchester.ac.uk.
Marcus J SwannSwann Scientific Consulting Ltd 110 Sandy Lane Lymm WA13 9HR UK.
Egor ZindyWellcome Trust Centre for Cell-Matrix Research UK t.jowitt@manchester.ac.uk.
Anthony J DayWellcome Trust Centre for Cell-Matrix Research UK t.jowitt@manchester.ac.uk.
Thomas A JowittWellcome Trust Centre for Cell-Matrix Research UK t.jowitt@manchester.ac.uk.ORCID https://orcid.org/0000-0002-4045-0933
Wellcome Centre for Cell-Matrix Research · GBScientific Consulting Group · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Two of the most important aspects of lipid bilayers that have increased their popularity in the field of nanotechnology and biosensors are their fluid nature, which is highly beneficial in ensuring the spatial organization of attached molecules, and the relative ease in which they can be manipulated to change the surface chemistry. Here we have used two different types of functionalized lipids to study the interaction of avidin, which is a common approach to attach further ligands for study. We have tested the commonly used Biotinyl-Cap-PE lipids at different molar percentages and reveal that avidin is not evenly distributed, but forms what looks like clusters even at low percentage occupancy which hampers the level of avidin that can be associated with the surface. We have then successfully employed the novel strategy of using PDP-PE lipids which contain a reducible disulphide to which we added maleamide-PEG-biotin spacers of different lengths. There is a more even distribution of avidin on these layers and thereby increasing the amount and efficiency of avidin association. The reduced levels of avidin that was being associated with the Biotinyl-Cap-PE layers as compared to the PDP-PE lipids could be analysed with QCM-D and interferometry approaches, but it was only with SEEC microscopy that the reason for the reduced occupancy was resolved.

Identifiers

PMID36132312
PMCPMC9417969
OpenAlexW3011497330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.